SCHEMBL5137429

SCHEMBL5137429

COc1c(C(=O)N(Cc2ccc3c(c2)OCO3)CC2CCCC2)cccc1-c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.44
HPGD P15428 3/20 0.44
MAPT P10636 1/20 0.44
GABRA1 P14867 1/20 0.43
GABRB2 P47870 1/20 0.43
MAPK1 P28482 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
USP2 O75604 1/20 0.42
TSHR P16473 2/20 0.41
OXTR P30559 4/20 0.41
AVPR1A P37288 4/20 0.41
GAA P10253 1/20 0.41
MCHR1 Q99705 1/20 0.41
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
NPSR1 Q6W5P4 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5136876 0.79 ALDH1A1 (0.59) ALDH1A1HPGDMAPTGABRA1GABRB2
SCHEMBL5134630 0.77 ALDH1A1 (0.62) ALDH1A1HPGDMAPTGABRA1GABRB2
SCHEMBL4766559 0.69 ALDH1A1 (0.55) ALDH1A1HPGDMAPTGABRA1GABRB2
SCHEMBL12320058 0.68 LPAR1 (0.51) HPGDGABRA1GABRB2OXTRAVPR1A
SCHEMBL5136528 0.68 GABRA1 (0.46) ALDH1A1HPGDMAPTGABRA1GABRB2
SCHEMBL5361256 0.68 GABRA1 (0.44) ALDH1A1HPGDMAPTGABRA1GABRB2
SCHEMBL14099478 0.67 ALDH1A1 (0.64) ALDH1A1HPGDMAPTMAPK1SMN1; SMN2
SCHEMBL4769015 0.67 ALDH1A1 (0.55) ALDH1A1HPGDMAPTMAPK1SMN1; SMN2
SCHEMBL5134793 0.67 ALDH1A1 (0.55) ALDH1A1HPGDMAPTGABRA1GABRB2
SCHEMBL5137374 0.65 CHRNB2 (0.42) ALDH1A1SMN1; SMN2LMNATDP1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1490044-A4 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORP (US) 2008-04-16 EP disclosed
EP-1490044-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2004-12-29 EP disclosed
WO-2003084524-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2003-10-16 WO disclosed